Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second

被引：0
|
作者：
Kim, Jin-Hyo [1 ]
Park, Sung-Soo [1 ]
Yoon, Jae-Ho [1 ]
Lee, Sung-Eun [1 ]
Kim, Hee-Je [1 ]
Min, Chang-Ki [1 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hematol Hosp, Coll Med, Dept Hematol, 222 Banpodaero, Seoul 06591, South Korea
来源：
BLOOD RESEARCH | 2022年 / 57卷 / 01期
关键词：
CD38;
D O I：
10.5045/br.2022.2021183
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 80
页数：5
相关论文
共 50 条
  • [41] Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma
    Chen, Pingping
    Ma, Jiexian
    Qian, Wensi
    Wu, Min
    Shen, Lin
    Xie, Yanhui
    MINERVA PEDIATRICS, 2024, 76 (01): : 121 - 123
  • [42] Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma
    Plesner, Torben
    Arkenau, Hendrik-Tobias
    Lokhorst, Henk M.
    Gimsing, Peter
    Krejcik, Jakub
    Lemech, Charlotte
    Minnema, Monique C.
    Lassen, Ulrik
    Laubach, Jacob P.
    Ahmadi, Tahamtan
    Yeh, Howard
    Guckert, Mary E.
    Feng, Huaibao
    Brun, Nikolai Constantin
    Lisby, Steen
    Basse, Linda
    Palumbo, Antonio
    Richardson, Paul G.
    BLOOD, 2014, 124 (21)
  • [43] SAFETY AND EFFICACY OF DARATUMUMAB WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR RELAPSED, REFRACTORY MULTIPLE MYELOMA
    Plesner, T.
    Arkenau, H. T.
    Lokhorst, H. M.
    Gimsing, P.
    Krejcik, J.
    Lemech, C.
    Minnema, M. C.
    Lassen, U.
    Ahmadi, T.
    Yeh, H.
    Guckert, M.
    Brun, N. C.
    Lisby, S.
    Basse, L.
    Palumbo, A.
    Richardson, P. G.
    HAEMATOLOGICA, 2014, 99 : 104 - 104
  • [44] Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas
    Moreno, David F.
    Clapes, Victoria
    Alfons Soler, Juan
    Gonzalez-Montes, Yolanda
    Gironella, Mercedes
    Motllo, Cristina
    Granell, Miquel
    Abella, Eugenia
    Garcia-Pintos, Marta
    Garcia-Guinon, Antoni
    Cabezudo, Elena
    Blade, Joan
    Rosinol, Laura
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (08): : 635 - 642
  • [45] EFFECTIVENESS AND SAFETY OF DARATUMUMAB IN MONOTHERAPY IN ADULT PATIENTS WITH RELAPSING AND REFRACTORY MULTIPLE MYELOMA (RRMM)
    Alarcon-Payer, C.
    Clavero Sanchez, M.
    Jimenez Morales, A.
    Salazar Bravo, M.
    Cornejo Calvo, M.
    Cano Dominguez, S.
    Rios Tamayo, R.
    Jurado Chacon, M.
    HAEMATOLOGICA, 2018, 103 : 122 - 122
  • [46] A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
    Joseph Mikhael
    Karim Belhadj-Merzoug
    Cyrille Hulin
    Laure Vincent
    Philippe Moreau
    Cristina Gasparetto
    Ludek Pour
    Ivan Spicka
    Ravi Vij
    Jeffrey Zonder
    Djordje Atanackovic
    Nashat Gabrail
    Thomas G. Martin
    Aurore Perrot
    Samira Bensfia
    Qilong Weng
    Claire Brillac
    Dorothée Semiond
    Sandrine Macé
    Kathryn P. Corzo
    Xavier Leleu
    Blood Cancer Journal, 11
  • [47] A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
    Mikhael, Joseph
    Belhadj-Merzoug, Karim
    Hulin, Cyrille
    Vincent, Laure
    Moreau, Philippe
    Gasparetto, Cristina
    Pour, Ludek
    Spicka, Ivan
    Vij, Ravi
    Zonder, Jeffrey
    Atanackovic, Djordje
    Gabrail, Nashat
    Martin, Thomas G.
    Perrot, Aurore
    Bensfia, Samira
    Weng, Qilong
    Brillac, Claire
    Semiond, Dorothee
    Mace, Sandrine
    Corzo, Kathryn P.
    Leleu, Xavier
    BLOOD CANCER JOURNAL, 2021, 11 (05)
  • [48] Efficacy of Once-Weekly Bortezomib with Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma
    Gut, Natalia
    Yucebay, Filiz
    Dempsey, Jessica
    Li, Junan
    Benson, Don M., Jr.
    BLOOD, 2018, 132
  • [49] Immunomodulation in Pomalidomide, Dexamethasone, and Daratumumab-Treated Patients with Relapsed/Refractory Multiple Myeloma
    Pierceall, William E.
    Amatangelo, Michael D.
    Bahlis, Nizar J.
    Siegel, David S.
    Rahman, Adeeb
    Van Oekelen, Oliver
    Neri, Paola
    Young, Mary
    Chung, Weiyuan
    Serbina, Natalya
    Parekh, Samir
    Agarwal, Amit
    Thakurta, Anjan
    CLINICAL CANCER RESEARCH, 2020, 26 (22) : 5895 - 5902
  • [50] Daratumumab with Pomalidomide and Dexamethasone at First Relapse in Relapsed and/or Refractory Multiple Myeloma ( RRMM) Patients
    不详
    BLOOD, 2021, 138
12345